Amn Healthcare Stock Price, News & Analysis

O.R. Staffing Solutions, a portfolio company of Argosy Healthcare Partners, has announced significant leadership changes with the appointment of Brent Bormaster as CEO, along with Mark Smith as Executive Chairman and Jerick Henley as Director to its Board.

Bormaster brings extensive experience from his previous role as President at AHS Staffing and an 18-year tenure at AMN Healthcare (NYSE: AMN) where he served as Divisional Vice President. The new leadership team, including Smith and Henley, previously collaborated in scaling and successfully exiting American Health Staffing Group (AHSG).

ORSS specializes in providing workforce solutions for operating rooms in acute care hospitals and ambulatory surgery centers, utilizing a clinician-led, operating room-centric approach known for faster onboarding and precise matching in surgical settings.

AMN Healthcare (NYSE:AMN) has released its 32nd annual physician recruiting incentives report, revealing that the average starting salary for physicians has reached $403,000. The comprehensive study shows significant salary variations across specialties, with orthopedic surgeons commanding the highest starting salary at $576,000, while pediatricians receive the lowest at $258,000.

The report highlights substantial year-over-year salary increases, with otolaryngologists seeing the largest gain of 36% to $487,000. Nurse practitioners are also experiencing rising compensation, with average starting salaries increasing 9.6% to $180,000. Additionally, physicians receive an average signing bonus of $38,315, relocation allowance of $12,619, and CME allowance of $4,073.

AMN Healthcare (NYSE:AMN), the leader in healthcare total talent solutions, has scheduled its Q2 2025 earnings conference call for Thursday, August 7, 2025, at 5:00 p.m. Eastern Time. The company will release its earnings report after market close at approximately 4:15 p.m. ET on the same day.

The call will be accessible via webcast and telephone, with registration required for dial-in access. In 2024, AMN's healthcare professionals served nearly 15 million patients across more than 2,100 healthcare systems, including 87% of top healthcare systems nationwide.

AMN Healthcare (NYSE: AMN) has announced the sale of its Smart Square® scheduling software to symplr® for $75 million, comprising $65 million upfront and a $10 million note due in 2026. The transaction includes a strategic commercial partnership between the two companies.

The partnership combines AMN's WorkWise platform's workforce planning, analytics, and AI capabilities with symplr's operational technology. This integration aims to enhance workforce optimization, scheduling, timekeeping, and administrative processes for healthcare organizations nationwide.

The collaboration allows AMN to focus on developing its WorkWise technology suite while leveraging symplr's expertise in operational software, creating a comprehensive solution for healthcare workforce management.

symplr has acquired Smart Square® scheduling software from AMN Healthcare (NYSE: AMN), enhancing its healthcare workforce management capabilities. The acquisition combines two Best in KLAS solutions, integrating Smart Square's AI-driven nurse and staff scheduling platform with symplr's existing healthcare operations software suite.

The strategic acquisition strengthens symplr's Operations Platform by adding advanced features including predictive analytics, real-time staffing adjustments, open-shift management, and nurse competency integration. Additionally, symplr and AMN Healthcare have established a commercial partnership to leverage their respective strengths in operational technology and healthcare workforce solutions.

Following the deal, AMN Healthcare will focus on developing its Workwise platform for workforce advisory, planning AI, staffing, and analytics solutions.

AMN Healthcare (NYSE: AMN), a leader in healthcare total talent solutions, has announced the appointment of Celia Huber to its Board of Directors, effective May 2, 2025. Huber, currently a Senior Partner at McKinsey & Company, brings over 30 years of experience in healthcare strategy and leadership.

As the leader of McKinsey's Board Services Practice in North America, Huber specializes in advising Fortune 500 boards on governance, succession planning, and organizational transformation. Her extensive background includes counseling healthcare systems and payors on strategy, merger integration, and risk management.

Huber currently serves on the AltaMed Foundation board and the Executive Committee of the California Business Roundtable, demonstrating her commitment to healthcare leadership and organizational governance.

A new survey by AMN Healthcare reveals a significant increase in physician appointment wait times across 15 major U.S. metropolitan areas. The average wait time has surged to 31 days, marking a 19% increase since 2022 and a 48% increase since 2004. Among specialties, Obstetrics/Gynecology has the longest average wait time at 42 days, followed by Gastroenterology (40 days) and Dermatology (36.5 days). Boston has the highest average wait time at 65 days, while Atlanta has the shortest at 12 days. The survey also found that 82% of physicians accept Medicare, but only 53% accept Medicaid. Some extreme cases include wait times of 291 days for dermatology in Portland and 231 days for obstetrics/gynecology in Boston.

AMN Healthcare's 2025 Survey of Registered Nurses reveals significant challenges facing the nursing profession. Based on responses from 12,000+ nurses, the survey shows that while 75% are satisfied with their career choice, 58% report burnout most days and only 39% plan to stay in their current positions within 12 months. Critical findings include: 33% of nurses are eligible for retirement, 64% experience compassion fatigue, and 49% feel undervalued by employers. The survey highlights demands for workplace improvements, with 81% citing flexible schedules as a potential solution. Only 34% currently have self-scheduling options. AMN Healthcare emphasizes the need for systemic changes, including advanced scheduling technologies, mentorship programs, and workplace violence prevention measures to address these challenges and improve nurse retention.

AMN Healthcare (NYSE: AMN) reported Q1 2025 financial results with revenue of $690 million, down 16% year-over-year. The company posted a GAAP loss of ($0.03) per share and adjusted EPS of $0.45. Key segment performance included: Nurse and Allied Solutions revenue at $413M (down 20% YoY), Physician and Leadership Solutions at $174M (down 8% YoY), and Technology and Workforce Solutions at $102M (down 9% YoY). Despite challenges, Q1 results exceeded guidance, with strong cash flow from operations at $93M. The company reduced debt by $60M, ending with a net leverage ratio of 3.1:1. For Q2 2025, AMN projects revenue between $645-660M, representing an 11-13% YoY decline.